Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

SBC Medical Group Holdings (SBC) Other Accumulated Expenses (2023 - 2025)

SBC Medical Group Holdings (SBC) has disclosed Other Accumulated Expenses for 3 consecutive years, with $4.6 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Other Accumulated Expenses fell 62.15% year-over-year to $4.6 million, compared with a TTM value of $4.6 million through Sep 2025, down 62.15%, and an annual FY2024 reading of $8.1 million, down 61.43% over the prior year.
  • Other Accumulated Expenses was $4.6 million for Q3 2025 at SBC Medical Group Holdings, down from $6.2 million in the prior quarter.
  • Across five years, Other Accumulated Expenses topped out at $21.0 million in Q4 2023 and bottomed at $4.6 million in Q3 2025.
  • Average Other Accumulated Expenses over 3 years is $10.1 million, with a median of $8.3 million recorded in 2024.
  • The sharpest move saw Other Accumulated Expenses plummeted 61.43% in 2024, then plummeted 62.15% in 2025.
  • Year by year, Other Accumulated Expenses stood at $21.0 million in 2023, then crashed by 61.43% to $8.1 million in 2024, then tumbled by 43.7% to $4.6 million in 2025.
  • Business Quant data shows Other Accumulated Expenses for SBC at $4.6 million in Q3 2025, $6.2 million in Q2 2025, and $8.6 million in Q1 2025.